Human mycoses: drugs and targets for emerging pathogens.
about
Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agentsEmerging drugs and vaccines for candidemiaLC/MS applications in drug developmentIn vitro antifungal activity and cytotoxicity of a novel membrane-active peptideAntifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug actionIdentification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistrySordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungiIn vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus speciesBacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologistsAspergillus fumigatus and aspergillosisSynergistic antimicrobial activity of metabolites produced by a nonobligate bacterial predatorCandida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target siteUpdate on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.Lipid-based amphotericin B for the treatment of fungal infections.Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.In vitro damage of Candida albicans biofilms by chitosanHeterogeneity of Pneumocystis sterol profiles of samples from different sites in the same pair of lungs suggests coinfection by distinct organism populations.Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition.Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicansVirulence of a phosphoribosylaminoimidazole carboxylase-deficient Candida albicans strain in an immunosuppressed murine model of systemic candidiasis.Population genomics of drug resistance in Candida albicans.In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.Antifungal agents: chemotherapeutic targets and immunologic strategies.Fungal infections: a growing threatSalivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva.Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiaeAntifungals targeted to protein modification: focus on protein N-myristoyltransferase.Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitorsActivity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans.Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patientsA yeast sterol auxotroph (erg25) is rescued by addition of azole antifungals and reduced levels of heme.Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides.β-(1,3)-Glucan Unmasking in Some Candida albicans Mutants Correlates with Increases in Cell Wall Surface Roughness and Decreases in Cell Wall Elasticity.Antifungal research strategies aiming for new targets.Pharmacoeconomics of voriconazole in the management of invasive fungal infections.Cutaneous bacterial species from Lithobates catesbeianus can inhibit pathogenic dermatophytes.Effect of polygodial on the mitochondrial ATPase of Saccharomyces cerevisiae.Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants
P2860
Q24676192-1F5DA211-26DB-496E-B71C-8ADB32AF239CQ26828993-AA5B4E36-4383-46F2-B435-C2F6907F8609Q28138241-6CF696A9-93A6-4A18-8F20-733C997D7EA2Q28343417-8D27E40D-996F-4B6A-8E56-854C04F668A0Q28343624-7D1F3AA4-0874-405C-B813-0151611F2198Q28369019-B4F84A28-051E-46A2-BC06-519E951AC9BFQ28369140-B0D7B9F5-F22D-4AC9-A874-0DBA70C7A9C8Q28379527-CEB1B91B-AD70-4FEB-8953-E4F60C4BC9C9Q28741795-37DF4A49-C7C7-40FD-8E1D-BAF0247B5BBEQ29617908-B0AE6CAF-6981-43AE-B341-93FF19969B11Q30805908-89553B82-E07D-4C5D-8A2B-219054C5CD58Q30827584-99B07D91-A2C7-4857-B23A-14DD437A1240Q31936121-C3E82B84-A443-45BD-9012-EA388FB7C652Q33604227-7EDD568F-FCE5-4144-B5C1-F883D40AD999Q33749111-04525816-B7F5-46E0-9E0E-13232FEE882AQ33962613-032388D3-4882-4102-8EE2-37E685BBB90DQ33971670-07501793-BF81-4A6B-A239-29F82B3D9B68Q33979139-7DC301A9-88E3-4700-BF5A-D0AE05836766Q33996119-ADA7FDFF-6FC2-4F80-B5C6-9B85020684F4Q34006967-DD38E4DF-4509-4552-A9DB-2C8780D41A4CQ34034817-D5BEE8B3-B009-4316-A915-864B1508510DQ34106775-AA725845-1DDC-45B1-ADE0-5CFF0EDE86F4Q34110440-AD773B2F-D6BE-4F6E-8C48-AAE4C86D6D19Q34400044-81B67186-D624-4193-A695-FF73F1F8B937Q34404601-C4E7EC05-FCCA-44C9-A693-B9955DE534AFQ34528899-C235DD5E-16BF-4EBC-9FAD-0CB5E3D6CF8FQ34617356-281BE7AA-38D0-45A8-9E6E-7451C6D6F344Q34768569-1DA32421-F172-426D-BE68-10BB50CEE8A4Q35127954-1A33BDF5-47C3-48CB-A705-C63B562FABB6Q35138591-2EEAEA56-8973-4BA4-9325-187BE8912D34Q35953363-378D164D-A934-4B0B-801A-28C8166E8D06Q36525223-5D5E6BA1-25E2-4901-B4FC-368454992713Q36588959-904ED72A-7945-4D9A-B881-0070237FF588Q37313642-86917CB9-AB56-48FF-8182-D1BBE0CBB48CQ37546944-5A56A018-1F99-469E-B65B-E6C5684DA839Q37588637-F05FA7A7-895F-4A9E-BA8A-9AF21314DCC7Q37820674-6AD33264-558C-4788-90F9-8B36433A67EBQ39093310-232DE76E-AC26-474A-907E-9F316FF3EAA7Q39474468-A8221A71-2E6C-4328-B77E-20F3C490CE1DQ39558473-DBC586CE-4598-4CB6-8E2F-3AD8D0FF3840
P2860
Human mycoses: drugs and targets for emerging pathogens.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Human mycoses: drugs and targets for emerging pathogens.
@en
type
label
Human mycoses: drugs and targets for emerging pathogens.
@en
prefLabel
Human mycoses: drugs and targets for emerging pathogens.
@en
P356
P1433
P1476
Human mycoses: drugs and targets for emerging pathogens.
@en
P2093
Georgopapadakou NH
P304
P356
10.1126/SCIENCE.8153622
P407
P577
1994-04-01T00:00:00Z